AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Sangamo Therapeutics to Present at the 38th Annual J.P. Morgan Healthcare Conference

January 9, 2020 GMT

BRISBANE, Calif.--(BUSINESS WIRE)--Jan 9, 2020--

Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that Sandy Macrae, CEO of Sangamo, will present a corporate overview at the 38 th Annual J.P. Morgan Healthcare Conference on Thursday, January 16 th at 8:30 a.m. PT in San Francisco.

The presentation will be webcast live and may be accessed via a link on the Sangamo Therapeutics website in the Investors and Media section under Events and Presentations.

About Sangamo Therapeutics

Sangamo Therapeutics is committed to translating ground-breaking science into genomic medicines with the potential to transform patients’ lives using gene therapy, ex vivo gene-edited cell therapy, and in vivo genome editing and gene regulation. For more information about Sangamo, visit www.sangamo.com.

View source version on businesswire.com:https://www.businesswire.com/news/home/20200109005263/en/

CONTACT: Investor Relations – Global

McDavid Stilwell

510-970-6000, x219

mstilwell@sangamo.com Media Inquiries – Global

Aron Feingold

510-970-6000, x421

afeingold@sangamo.com

KEYWORD: CALIFORNIA UNITED STATES NORTH AMERICA

INDUSTRY KEYWORD: MEDICAL DEVICES HEALTH GENETICS CLINICAL TRIALS PHARMACEUTICAL BIOTECHNOLOGY

SOURCE: Sangamo Therapeutics, Inc.

Copyright Business Wire 2020.

PUB: 01/09/2020 08:30 AM/DISC: 01/09/2020 08:30 AM

http://www.businesswire.com/news/home/20200109005263/en